新生血管性年龄相关性黄斑变性玻璃体内治疗中的离群眼科医生
这项前瞻性设计的数据库研究纳入2018年7月至2023年4月在澳大利亚开始血管内皮生长因子抑制剂治疗的新生血管性年龄相关性黄斑变性初治眼,用漏斗图按校正后12个月视力变化均值将眼科医生分为高离群、非离群和低离群。38名医生治疗的1266只眼被分为1名高离群、34名非离群和3名低离群,低离群患者注射次数更少、治疗间隔更长、视网膜内积液就诊比例更高。
要点
- 低离群眼科医生患者12个月视力变化均值2.5字母,低于非离群的5.1字母。
- 低离群注射次数均值7.1次,少于非离群的7.7次(p=0.009)。
- 低离群患者视网膜内积液就诊比例59%,高于非离群的29%(p<0.001)。
核心结论
- 低离群眼科医生的患眼注射次数更少、治疗间隔更长、视网膜内积液就诊比例更高。
- 作者认为建立向低离群医生匿名告知其表现的系统有助于改善整体医疗质量。
研究设计与样本
- 前瞻性设计的数据库研究,纳入2018年7月至2023年4月在澳大利亚开始血管内皮生长因子抑制剂治疗的新生血管性年龄相关性黄斑变性初治眼。
- 共38名眼科医生、1266只眼(男性35%;平均年龄81岁),按校正后12个月视力变化均值的漏斗图分为高离群、非离群和低离群。
主要发现
- 38名医生分为1名高离群、34名非离群和3名低离群,12个月视力变化均值分别为7.5、5.1和2.5字母。
- 高离群注射次数均值8.6次,多于非离群的7.7次(p<0.001);低离群均值7.1次,少于非离群的7.7次(p=0.009)。
- 末次注射间隔在高离群患眼最短为9.4周,其次为非离群10.8周(p=0.04,对比高离群),低离群为11.8周(p=0.22,对比非离群)。
- 低离群患者视网膜内积液就诊比例59%,高于非离群的29%(p<0.001)和高离群患者的31%(p<0.001)。
临床怎么用
- 作者认为建立向低离群医生匿名告知其表现的系统有助于改善整体医疗质量。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To compare individual ophthalmologists grouped as outliers or non-outliers based on the mean 12-month visual acuity (VA) outcomes for their patients with neovascular age-related macular degeneration (nAMD). METHODS: This prospectively designed database study included treatment-naïve eyes with nAMD starting vascular endothelial growth factor inhibitors between July 2018 and April 2023 in Australia. Ophthalmologists were classified into high outliers, non-outliers and low outliers with a funnel plot of the adjusted mean 12-month VA change. The number of injections, last injection interval and proportion of visits where choroidal neovascularisation was active were compared between the groups. RESULTS: 38 ophthalmologists who treated a total of 1266 eyes (male, 35%; mean age, 81 years old) were classified into 1 high outlier, 34 non-outliers and 3 low outliers (mean VA change, 7.5, 5.1 and 2.5 letters, respectively). The high outlier gave significantly more injections than the non-outliers (mean, 8.6 vs 7.7; p<0.001), while the low outliers administered significantly fewer injections than the non-outliers (mean, 7.1 vs 7.7; p=0.009). The last injection interval was shortest in the high outlier's eyes (9.4 weeks), followed by non-outliers' (10.8 weeks; p=0.04 (vs high outlier's)) and low outliers' (11.8 weeks; p=0.22 (vs non-outliers')). The low outliers' patients had more visits with intraretinal fluid (59%) than non-outliers' (29%; p<0.001) and high outlier's patients (31%; p<0.001). CONCLUSION: The low outliers' eyes had fewer injections, a longer treatment interval and more visits with intraretinal fluid. Building a system through which low outliers are anonymously notified of their performance would help improve general quality of care.
引用
- Hashimoto Y, Hunt AR, Wells JM, et al. Outlier ophthalmologists in the treatment of neovascular age-related macular degeneration with intravitreal therapy. Br J Ophthalmol. 2025. PMID: 39542710. doi:10.1136/bjo-2024-326024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。